Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
TDAC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.72 Med: -0.46 Max: -0.21
Current: -0.57
During the past 4 years, the highest Debt-to-EBITDA Ratio of Translational Development Acquisition was -0.21. The lowest was -0.72. And the median was -0.46.
TDAC's Debt-to-EBITDA is ranked worse than 100% of 116
companies
in the Diversified Financial Services industry
Industry Median: 5.755
vs TDAC: -0.57
Translational Development Acquisition (NAS:TDAC) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Translational Development Acquisition Debt-to-EBITDA Related Terms
Translational Development Acquisition Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translational Development Acquisition Debt-to-EBITDA Chart
Translational Development Acquisition Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Debt-to-EBITDA
N/A
-0.72
0.00
-0.21
Translational Development Acquisition Quarterly Data
TDAC vs WLII, AESP, HAVA: Debt-to-EBITDA Comparison
For the Shell Companies subindustry, Translational Development Acquisition's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Translational Development Acquisition Debt-to-EBITDA vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Translational Development Acquisition's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Translational Development Acquisition's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Translational Development Acquisition (TDAC) has a Debt-to-EBITDA of -0.45 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Translational Development Acquisition. According to the industry distribution chart, Translational Development Acquisition ranks #999999 out of 116 companies in the Diversified Financial Services industry.
Is Translational Development Acquisition's Debt-to-EBITDA too high?
Translational Development Acquisition's current Debt-to-EBITDA is -0.45. Based on the distribution chart, Translational Development Acquisition ranks #999999 out of 116 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Translational Development Acquisition has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Translational Development Acquisition's Debt-to-EBITDA compare to WLII and AESP?
According to the Diversified Financial Services industry distribution chart, Translational Development Acquisition ranks #999999 out of 116 companies for Debt-to-EBITDA. This places Translational Development Acquisition in the lower half of its industry. The industry median Debt-to-EBITDA is 5.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Diversified Financial Services company?
The median Debt-to-EBITDA among Diversified Financial Services companies is 5.76, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Translational Development Acquisition. For the Diversified Financial Services industry, the median Debt-to-EBITDA is 5.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Translational Development Acquisition's current Debt-to-EBITDA is -0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Translational Development Acquisition stock overvalued right now?
Translational Development Acquisition (TDAC) has a current Debt-to-EBITDA of -0.45. The current Debt-to-EBITDA is -0.45. Translational Development Acquisition's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Translational Development Acquisition (TDAC), the current Debt-to-EBITDA is -0.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Translational Development Acquisition Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TDAC has been successfully added to your 
